These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy. Zhou GB; Zhang J; Wang ZY; Chen SJ; Chen Z Philos Trans R Soc Lond B Biol Sci; 2007 Jun; 362(1482):959-71. PubMed ID: 17317642 [TBL] [Abstract][Full Text] [Related]
24. Promyelocyte morphology. Differentiation of acute promyelocytic leukemia from benign myeloid proliferations. Innes DJ; Hess CE; Bertholf MF; Wade P Am J Clin Pathol; 1987 Dec; 88(6):725-9. PubMed ID: 3479892 [TBL] [Abstract][Full Text] [Related]
25. Restitution of normal marrow morphology and karyotype in acute refractory acute promyelocytic leukaemia with all-trans retinoic acid. Creagh MD; Clark DJ; Collin RC Br J Haematol; 1991 Aug; 78(4):572. PubMed ID: 1911349 [No Abstract] [Full Text] [Related]
26. [Complete remission induced by combined treatment with all-trans retinoic acid (ATRA) and granulocyte colony-stimulating factor (G-CSF) in a patient with relapsed acute promyelocytic leukemia]. Wakayama T; Furuya H; Takagi C; Ichiba S; Kato Y Rinsho Ketsueki; 1994 Nov; 35(11):1315-21. PubMed ID: 7529843 [TBL] [Abstract][Full Text] [Related]
27. In vivo differentiation of leukaemic blasts and effect of low dose Ara-C in a marrow grafted patient with leukaemic relapse. Mittermüller J; Kolb HJ; Gerhartz HH; Wilmanns W Br J Haematol; 1986 Apr; 62(4):757-62. PubMed ID: 2938618 [TBL] [Abstract][Full Text] [Related]
28. [All-trans retinoic acid-induced myelomonocytoid differentiation in acute promyelocytic leukemia]. Mori H; Fujiwara H; Takahashi N; Tada J; Higuchi T; Harada H; Niikura H; Omine M; Fujita K Rinsho Ketsueki; 1997 May; 38(5):440-4. PubMed ID: 9194390 [TBL] [Abstract][Full Text] [Related]
29. Treatment of promyelocytic blast crisis of chronic myelogenous leukemia with all trans-retinoic acid. Wiernik PH; Dutcher JP; Paietta E; Hittelman WN; Vyas R; Strack M; Castaigne S; Degos L; Gallagher RE Leukemia; 1991 Jun; 5(6):504-9. PubMed ID: 2056773 [TBL] [Abstract][Full Text] [Related]
30. Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha. Drach J; McQueen T; Engel H; Andreeff M; Robertson KA; Collins SJ; Malavasi F; Mehta K Cancer Res; 1994 Apr; 54(7):1746-52. PubMed ID: 7511050 [TBL] [Abstract][Full Text] [Related]
31. [Complete remission without marrow aplasia phase in a patient with acute promyelocytic leukosis treated with aggressive chemotherapy]. del Potro Gómez E; Martínez Martínez R; López Martín JC; Díaz Morfa M; Díaz Mediavilla J; Espinos Pérez D An Med Interna; 1989 May; 6(5):255-6. PubMed ID: 2491539 [TBL] [Abstract][Full Text] [Related]
32. All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York Study. Frankel SR; Eardley A; Heller G; Berman E; Miller WH; Dmitrovsky E; Warrell RP Ann Intern Med; 1994 Feb; 120(4):278-86. PubMed ID: 8291820 [TBL] [Abstract][Full Text] [Related]
33. New facts and speculations on human myeloid leukemias. Breitman TR; Gallo RC Blood Cells; 1981; 7(1):79-89. PubMed ID: 6964818 [TBL] [Abstract][Full Text] [Related]
34. Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial. Burnett AK; Russell NH; Hills RK; Bowen D; Kell J; Knapper S; Morgan YG; Lok J; Grech A; Jones G; Khwaja A; Friis L; McMullin MF; Hunter A; Clark RE; Grimwade D; Lancet Oncol; 2015 Oct; 16(13):1295-305. PubMed ID: 26384238 [TBL] [Abstract][Full Text] [Related]
35. Oscillations of marrow culture growth in acute myeloid leukemia during remission induction and remission. Gustavsson A; Olofsson T; Olsson I Acta Haematol; 1979; 62(5-6):241-6. PubMed ID: 121664 [TBL] [Abstract][Full Text] [Related]
36. Bone marrow necrosis following ALL-trans retinoic acid therapy for acute promyelocytic leukaemia. Dreosti LM; Bezwoda W; Gunter K Leuk Lymphoma; 1994 Apr; 13(3-4):353-6. PubMed ID: 8049655 [TBL] [Abstract][Full Text] [Related]
37. A characteristic pattern of leukemic cell differentiation without cytoreduction during remission induction in acute promyelocytic leukemia. Kantarjian HM; Keating MJ; McCredie KB; Beran M; Walters R; Dalton WT; Hittleman W; Freireich EJ J Clin Oncol; 1985 Jun; 3(6):793-8. PubMed ID: 3859586 [TBL] [Abstract][Full Text] [Related]
38. [Acute promyelocytic leukemia (APL) resulting in broad cerebral infarction during all-trans retinoic acid (ATRA) treatment]. Ikeda Y; Yoshinaga K; Iki S; Ohbayashi Y; Urabe A Rinsho Ketsueki; 1994 Feb; 35(2):183-7. PubMed ID: 8139118 [TBL] [Abstract][Full Text] [Related]